November 17, 2023
1 min watch
Save
VIDEO: Development of VisioLite ophthalmic laser system for presbyopia advances
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Mitchell A. Jackson, MD, discusses the laser scleral microporation device with real-time OCT imaging.
“We actually get really on-live, on-tissue depth measurements to make sure we’re hitting the proper depth of penetration in the sclera to treat presbyopia,” he said.
According to Jackson, clinical trials in the United States for the VisioLite ophthalmic laser system (Ace Vision Group) will begin in 2024.
Published by:
Sources/Disclosures
Collapse
Source:
Jackson M. Using real-time SS OCT and automated tissue segmentation to optimize laser scleral microporation therapy. Presented at: American Academy of Ophthalmology meeting; Nov. 3-6, 2023; San Francisco.
Disclosures:
Jackson reports being the global medical director and a shareholder for Ace Vision Group.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.